Donor lymphocyte infusions and IL-2 as adaptive immunotherapy for patients with advanced malignancies undergoing high-dose chemotherapy and autologous stem cell transplant.

被引：0
|
作者：
Raptis, A [1 ]
Ballester, O [1 ]
Grutsch, JF [1 ]
Williams, S [1 ]
Tan, B [1 ]
Wilcox, P [1 ]
Payne, M [1 ]
Braun, B [1 ]
机构：
[1] Midwestern Reg Med Ctr, Bone Marow Transplant Dept, Zion, IL USA
来源：
BLOOD | 2002年 / 100卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
5381
引用
收藏
页码：452B / 452B
页数：1
相关论文
共 50 条
  • [1] Adoptive immunotherapy with donor lymphocyte infusions (DLI) and IL-2 after high-dose therapy (HDT) and autologous stem cell (ASC) rescue for relapsed/refractory multiple myeloma.
    Ballester, O
    Fang, T
    Bruno, G
    Willcox, P
    Vashi, P
    Payne, M
    Eldibany, M
    Tan, B
    BLOOD, 2000, 96 (11) : 196A - 196A
  • [2] High-Dose Chemotherapy and Autologous Stem Cell Transplant
    Adra, Nabil
    Abonour, Rafat
    UROLOGIC CLINICS OF NORTH AMERICA, 2019, 46 (03) : 439 - +
  • [3] Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
    Ballester, OF
    Fang, T
    Raptis, A
    Ballester, G
    Wilcox, P
    Hiemenz, J
    Tan, B
    BONE MARROW TRANSPLANTATION, 2004, 34 (05) : 419 - 423
  • [4] Adoptive immunotherapy with donor lymphocyte infusions and interleukin-2 after high-dose therapy and autologous stem cell rescue for multiple myeloma
    O F Ballester
    T Fang
    A Raptis
    G Ballester
    P Wilcox
    J Hiemenz
    B Tan
    Bone Marrow Transplantation, 2004, 34 : 419 - 423
  • [5] Interleukin-2 (IL-2) post high dose chemotherapy mobilized autologous stem cell transplant (ASCT) for hematologic malignancies.
    Oliveira, JSR
    Cecyn, KZ
    Parisio, K
    Faria, JR
    Ribeiro, MSS
    Chauffaille, MDLF
    Raineri, G
    BLOOD, 2001, 98 (11) : 396B - 397B
  • [6] Prolonged administration of aprepitant does not increase toxicity in patients undergoing high dose chemotherapy and autologous stem cell transplant.
    Junagadhwalla, M
    Chilton, J
    Gentile, T
    BLOOD, 2005, 106 (11) : 417B - 417B
  • [7] High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma
    Lahoud, Oscar B.
    Sauter, Craig S.
    Hamlin, Paul A.
    Dahi, Parastoo Bahrami
    CURRENT ONCOLOGY REPORTS, 2015, 17 (09)
  • [8] High-Dose Chemotherapy and Autologous Stem Cell Transplant in Older Patients with Lymphoma
    Oscar B. Lahoud
    Craig S. Sauter
    Paul A. Hamlin
    Parastoo Bahrami Dahi
    Current Oncology Reports, 2015, 17
  • [9] PHARMACOKINETICS AND PHARMACODYNAMICS OF HIGH DOSE MELPHALAN IN MULTIPLE MYELOMA PATIENTS UNDERGOING AUTOLOGOUS STEM CELL TRANSPLANT.
    Cho, Y.
    Wang, J.
    Gao, Y.
    Li, J.
    Lamprecht, M.
    Jukich, M.
    Schaaf, L. J.
    Poi, M.
    Hofmeister, C. C.
    Phelps, M. A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2014, 95 : S38 - S38
  • [10] High-dose chemotherapy and autologous hematopoietic stem cell transplantation in patients with second primary malignancies
    Fetscher, S
    Finke, J
    Engelhardt, R
    Mertelsmann, R
    Lange, W
    HEMATOLOGY AND CELL THERAPY, 1997, 39 (02): : 79 - 83
12345